Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from GSAID Logo

EPI_ISL ID Virus name Region Country Collection Date Navigate
EPI_ISL ID: EPI_ISL_19389487 Virus name: hCoV-19/Canada/ON-PHL-202412786/2024 Region: North America Country: Canada Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19389485 Virus name: hCoV-19/Canada/ON-PHL-202412784/2024 Region: North America Country: Canada Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19387699 Virus name: hCoV-19/USA/NV-SNPHL-817954/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386796 Virus name: hCoV-19/Canada/ON-PHL-202412712/2024 Region: North America Country: Canada Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386155 Virus name: hCoV-19/USA/NY-GBW-GKISBBBC33080/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386105 Virus name: hCoV-19/USA/NY-GBW-GKPLAAAA29910/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386082 Virus name: hCoV-19/USA/NY-GBW-GKPLAAAA31654/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383678 Virus name: hCoV-19/Japan/FR088-0187/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383677 Virus name: hCoV-19/Japan/FR088-0188/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383562 Virus name: hCoV-19/USA/IA-SHL-2488238/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383530 Virus name: hCoV-19/USA/IA-SHL-2487865/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383083 Virus name: hCoV-19/Japan/FR050-0256/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383082 Virus name: hCoV-19/Japan/FR050-0257/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19380795 Virus name: hCoV-19/Japan/FR001-0257/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19380790 Virus name: hCoV-19/Japan/FR001-0262/2024 Region: Asia Country: Japan Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386102 Virus name: hCoV-19/USA/WA-GBW-GKISBBBC76279/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386074 Virus name: hCoV-19/USA/VA-GBW-GKISBBBD46342/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386819 Virus name: hCoV-19/Canada/ON-PHL-202412735/2024 Region: North America Country: Canada Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19386817 Virus name: hCoV-19/Canada/ON-PHL-202412733/2024 Region: North America Country: Canada Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19391020 Virus name: hCoV-19/Sweden/AB-01_SE100_24CS501536/2024 Region: Europe Country: Sweden Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19390980 Virus name: hCoV-19/Sweden/AB-01_SE100_24CS501500/2024 Region: Europe Country: Sweden Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19383543 Virus name: hCoV-19/USA/IA-SHL-2487866/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19394965 Virus name: hCoV-19/USA/NC-CDC-LC1118826/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19394964 Virus name: hCoV-19/USA/VA-CDC-LC1118735/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details
EPI_ISL ID: EPI_ISL_19394963 Virus name: hCoV-19/USA/NC-CDC-LC1118798/2024 Region: North America Country: USA Collection Date: 2024-08-29 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions